Ignyta (RXDX) Receives Daily News Impact Score of

Therefore 0 are positive. Piper Jaffray maintained the shares of WAFD in report on Thursday, October 5 with "Hold" rating. Keefe Bruyette & Woods maintained Washington Federal Inc. (NASDAQ:WAFD) rating on Monday, July 24. Keefe Bruyette & Woods has "Hold" rating and $3400 target. On Thursday, September 7 the stock rating was maintained by RBC Capital Markets with "Hold". See Washington Federal Inc.

The stock of Ignyta Inc (NASDAQ:RXDX) is a huge mover today! About 443,160 shares traded. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $19.50. We have $12.63 PT which if reached, will make NASDAQ:RXDX worth $61.77 million less.

Ignyta, Inc is a biotechnology company. The Company is focused on precision medicine in oncology. It now has negative earnings. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients.

Investors sentiment increased to 2.96 in 2017 Q2. Its up 1.63, from 1.33 in 2017Q1. It is positive, as 8 investors sold RXDX shares while 16 reduced holdings.

Institutional investors and hedge funds have recently made changes to their positions in the business. Citigroup owns 0% invested in Ignyta Inc (NASDAQ:RXDX) for 330 shares. Cubist Systematic Strategies Ltd Liability Com accumulated 637 shares. Iguana Limited Co owns 50,000 shares. Lombard Odier Asset Mgmt (Usa) reported 575,000 shares. Moore Cap Management Lp reported 0.02% stake. State Of Wisconsin Investment Board holds 0% or 34,000 shares. Great Point Limited Liability Corporation stated it has 3.24% of its portfolio in Ignyta Inc (NASDAQ:RXDX). Fred Alger Inc holds 32,000 shares or 0% of its portfolio. Farallon Cap Mngmt Ltd invested 0.12% of its portfolio in Ignyta Inc (NASDAQ:RXDX). Jpmorgan Chase invested 0% in Ignyta Inc (NASDAQ:RXDX).

The company is now up by 1.78% percent from yesterday's close.

Among 6 analysts covering Ignyta (NASDAQ:RXDX), 6 have Buy rating, 0 Sell and 0 Hold. Ignyta has a 52-week low of $4.15 and a 52-week high of $14.70. $21's average target is 49.47% above currents $14.05 stock price. Whole Foods Market Inc had 62 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has "Buy" rating by Cantor Fitzgerald given on Sunday, June 4. The rating was initiated by Credit Suisse on Thursday, January 21 with "Outperform". The firm has "Buy" rating by Cantor Fitzgerald given on Monday, July 10. The firm earned "Overweight" rating on Thursday, June 23 by JP Morgan. On Monday, October 26 the stock rating was initiated by Canaccord Genuity with "Buy". Jefferies initiated the stock with "Buy" rating in Friday, October 23 report. The stock has "Outperform" rating by Credit Suisse on Tuesday, March 15. The rating was maintained by Benchmark on Wednesday, November 2 with "Sell".

Analysts await Ignyta Inc (NASDAQ:RXDX) to report earnings on November, 6. They expect $0.43 earnings per share, down 12.24% or $0.06 from last year's $0.49 per share. After $-0.56 actual earnings per share reported by Ignyta Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

About 750,464 shares traded. Washington Federal Inc. (NASDAQ:WAFD) has risen 33.59% since October 12, 2016 and is uptrending. It has outperformed by 16.89% the S&P500. Bank of America downgraded Whole Foods Market, Inc. Capital Investment Counsel Inc who had been investing in Whole Foods Mkt Inc for a number of months, seems to be less bullish one the $13.45B market cap company.